Month 2018
Pyrazole and Benzimidazole-derived Ligands
MeOH (charcoaled); crystals were obtained suitable for X-
ray diffraction; brown solid; yield: 55%; M.p. 107–110°C;
1H NMR 500 (DMSO- d6): δ 9.11 (d, 1H, J = 8.45), 8.52
(d, 1H, J = 8.96), 8.25 (d, 1H J = 8.96), 8.09 (d, 1H,
J = 8.20), 8.01 (d, 1H, J = 8.00), 7.89 (d, 1H, J = 7.95),
7.81 (t, 1H, J = 7.64), 7.67 (t, 1H, J = 7.70), 7.58 (t, 1H,
J = 7.45), 7.38 (t, 1H, J = 7.46), 2.62 (s, 3); IR (cmꢀ1):
3051, 2916, 1620, 1599, 1433, 1397, 1339, 1217, 1084,
823, 737; FAB-MS: m/z 260.118, Calcd. for (M + 1)+,
260.118; Anal., calculated for C17H13N3: C, 78.7; H, 5.05;
N, 16.2. Found: C, 78.7; H, 5.42; N, 16.3.
7.12–7.34 (2 H, m), 6.72–6.92 (3 H, m), 6.34 (1 H, m),
2.32 (3 H, m); IR (cmꢀ1): 3400, 3060, 2940, 1594, 1570,
1550, 1465, 1440, 1363, 1210, 1097, 982, 850; CI-MS:
m/z 252.112, Calcd. for (M
+
1)+, 252.113;
C15H13N3O.1H2O: C, 66.9; H, 5.61; N, 15.6. Found: C,
66.6; H, 5.51; N, 15.6.
2-(3-Methyl-1-(quinolin-2-yl)-1H-pyrazol-5-yl)phenol
(L8).
Salicyloylacetone (2.5 mmole, 0.45 g) and 2-
hydrazinoquinoline (2.5 mmole, 0.40 g) were refluxed in
EtOH for 3 days, the solution was cooled down, filtered
off, and recrystallized from MeCN (charcoaled); crystals
were obtained suitable for X-ray diffraction; white solid;
2-(3-Methyl-4,5,6,7-tetrahydro-2H-indazol-2-yl)quinoline
(L5). A sample of 2-acetylcyclohexanone (1.7 mmole,
0.27 g) and 2-hydrazinoquinoline (1.7 mmole, 0.24 g)
1
yield: 63%, M.p. 209–211°C; H NMR 500 (DMSO-d6):
δ 9.22 (1 H, s), 8.42 (1 H, d, J = 8.84), 7.96 (1 H, d,
J = 8.08), 7.86 (1 H, t, J = 7.70), 7.64 (1 H, t, J = 7.65),
7.52 (1 H, t, J = 7.50), 7.32 (1 H, d, J = 8.40), 7.26 (1 H,
d, J = 7.48), 7.18 (1 H, m), 6.88 (1 H, t, J = 7.45), 6.68
(1 H, d, J = 8.11), 6.34 (1 H, s), 2.36 (3 H, s). IR (cmꢀ1):
3350, 3090, 2935, 1598, 1550, 1480, 1447, 1379,
1267, 1184, 1108, 944, 827, 790, 765, 755; APCI-MS: m/z
302.128, Calcd. for (M + 1)+, 302.129; C19H15N3O.1H2O:
C, 71.5; H, 5.37; N, 13.2. Found: C, 71.3; H, 4.98; N, 13.2.
were refluxed in iPrOH, for 2 days, the reaction mixture
rotavapored down to dryness, resulting a brown oil
residue from which a white power was obtained through
recrystallization from MeOH (charcoaled); crystals were
obtained suitable for X-ray diffraction; white solid; yield:
1
65%; M.p. 110–112°C; H NMR 500 (CDCl3): δ 8.22 (1
H, d, J = 8.75), 8.09 (1 H, d, J = 8.59), 7.90 (1 H, d,
J = 7.28), 7.80 (1 H, d, J = 8.25), 7.68 (1 H, t, J = 7.34),
7.48 (1 H, t, J = 6.68), 2.76 (4 H, m), 2.52 (2 H, m), 1.82
(5 H, m); IR (cmꢀ1): 3055, 2921, 1616, 1600, 1502,
1422, 1367, 1049, 954, 829, 756; CI-MS: m/z 263.141,
Calcd. for (M+), 263.142; Anal., calculated for C17H17N3:
C, 77.5; H, 6.51; N, 16.0. Found: C, 77.6; H, 6.54; N, 15.9.
(1Z,3Z)-N1,N3-bis(5-phenyl-1H-pyrazol-3-yl)isoindoline-
1,3-diimine (L9). Pyrazole (0.95 g, 6 mmol) was mixed
with phthalonitrile (0.38 g, 3 mmol) in a test tube, which
was inserted into an aluminum block on a hotplate,
heated to 175°C for 5 h, resulted in deep red mass, which
was then dissolved in hot DMF (N,N-dimethylformamide),
after which water was added to the reaction mixture, until
red crystals were obtained, yield: 81%. In the solventless
melt method, phthalonitrile was thus simply heated with 3-
amino-5-phenylpyrazole, while in the microwave method,
ethylene glycol was added as a microwave absorber.
Single crystals were grown in NMP; M.p. >220°C; IR
(cmꢀ1): 3300, 3060, 1633, 1564, 1482, 1300, 1203, 856,
803, 755. APCI-MS: m/z 430.181, Calcd. for (M + 1)+,
430.180; C26H19N.7 0.5 H2O: C, 71.2; H, 4.60; N, 22.4:
2-(3,5-Di-tert-butyl-1H-pyrazol-1-yl)quinolone (L6).
L6
was prepared by refluxing 1.33 mL (6.37 mmol) of
2,2,6,6-tetramethyl-2,5-heptanedione and 1.01
g
(6.37 mmol) of 2-hydrazinoquinoline in 30 mL of
ethylene glycol for 24 h. The solution was cooled to
room temperature, water was added to the reaction
mixture, until a precipitate was obtained. The crude
ligand recrystallized from MeOH (charcoaled); crystals
were obtained suitable for X-ray diffraction; yellow solid;
1
yield: 86%; M.p. 134–137°C; H NMR 500 (DMSO-d6):
1
δ 8.58 (1 H, d, J = 8.60), 8.09 (1 H, d, J = 8.26), 7.98 (1
H, d, J = 8.48), 7.84 (1 H, t, J = 7.63), 7.76 (1 H, d,
J = 8.65), 7.68 (1 H, t, J = 7.38), 6.28 (1 H, s), 1.36 (9
H, s), 1.28 (9 H, s); IR (cmꢀ1): 3049, 2958, 1618, 1597,
1502, 1440, 1358, 1245, 1015, 994, 835, 762; CI-MS:
m/z 308.213, Cacld. for (M + 1)+, 308.212; Anal. Calcd.
for C20H25N3. 0.25 CH3OH: C, 77.1; H, 8.31; N, 13.3;
found, C, 77.4; H, 7.92; N, 13.5.
2-(3-Methyl-1-(pyridin-2-yl)-1H-pyrazol-5-yl)phenol (L7).
Salicyloylacetone (2.0 mmole, 0.36 g, Frinton) and 2-
hydrazinopyridine (2.0 mmole, 0.22 g) were refluxed in
EtOH for 3 days, after which the product was filtered off
from the cooled solution, and recrystallized from MeCN
(charcoaled); crystals were obtained suitable for X-ray
diffraction; yellow solid; yield: 82%, M.p. 154–156°C;
1H NMR 500 (DMSO-d6): δ 9.32 (1 H, d, J = 6.81), 8.21
(1 H, d, J = 6.22), 7.94 (1 H, t, J = 7.81), 7.64 (1 H, m),
found: C, 71.6; H, 4.25; N, 22.7, H NMR 500 (DMSO-
d6): δ 13.34 (2 H, s), 8.01 (6 H, d, J = 7.42), 7.72 (2 H,
m), 7.50 (6 H, m), 7.32 (2 H, s), 6.81 (1 H, s).
(1Z,3Z)-N1,N3-bis(5-methyl-1H-pyrazol-3-yl)isoindoline-
1,3-diimine (L10). L10 was prepared by the solventless
melt method: 0.38 g (3 mmol) of phthalonitrile fused
with 0.95 g (6 mmol) of 3-amino-5-phenylpyrazole for
3 h, 180–190°C gave 1.25 g red crystals of crude product
when subsequently digested in hot DMF and ppted. with
hot water. Recrystallization from wet DMF (charcoal)
gave 0.50 g (40%) golden-buff microcrystals after drying
in vacuo at 100°C. Crystals suitable for X-ray diffraction
1
were obtained from DMF; M.p. >220°C; H NMR 500
(DMSO-d6): δ 12.50 (2 H, d, J = 6.38), 11.84 (1 H, d,
J = 6.48), 7.98 (2 H, d, J = 5.37), 7.72 (2 H, d, J = 6.52),
6.10 (2 H, d, J = 5.64), 2.32 (6 H, m); IR (cmꢀ1): 3233,
3059, 2985, 1629, 1566, 1213, 1120, 863, 780, 730;
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet